Investments
75Portfolio Exits
10Funds
4About LYFE Capital
LYFE Capital operates as a life sciences investment firm. LYFE Capital provides capital to multi-stage companies that are primarily based throughout China and North America. The firm was founded in 2015 and is based in Jingan, Shanghai.
LYFE Capital Headquarter Location
Park Place, 1601 West Nanjing Road Suite 3204-3205
Jingan, Shanghai, 200040,
China
(+86) 21-5220-0390
Latest LYFE Capital News
May 16, 2022
All Rights Reserved. Disclaimer: The views, opinions, forecasts, and statements made by our hosts and guests are the personal views of those respective individuals and may or may not be either endorsed or accepted by China Money Network Limited or the companies with which these individuals are employed. Posting....
LYFE Capital Investments
75 Investments
LYFE Capital has made 75 investments. Their latest investment was in ProfoundBio as part of their Series A - II on June 6, 2022.
LYFE Capital Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
6/2/2022 | Series A - II | ProfoundBio | $70M | No | 6 | |
5/16/2022 | Series A - II | Starna Therapeutics | $22.1M | Yes | 5 | |
5/9/2022 | Series A - II | Bioeast Biotech | $22.7M | Yes | 2 | |
5/9/2022 | Series B | |||||
4/29/2022 | Series A |
Date | 6/2/2022 | 5/16/2022 | 5/9/2022 | 5/9/2022 | 4/29/2022 |
|---|---|---|---|---|---|
Round | Series A - II | Series A - II | Series A - II | Series B | Series A |
Company | ProfoundBio | Starna Therapeutics | Bioeast Biotech | ||
Amount | $70M | $22.1M | $22.7M | ||
New? | No | Yes | Yes | ||
Co-Investors | |||||
Sources | 6 | 5 | 2 |
LYFE Capital Portfolio Exits
10 Portfolio Exits
LYFE Capital has 10 portfolio exits. Their latest portfolio exit was Ruike Biotechnology on March 31, 2022.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
3/31/2022 | IPO | Public | 1 | ||
12/10/2021 | IPO | Public | 1 | ||
11/15/2021 | IPO | Public | 2 | ||
Date | 3/31/2022 | 12/10/2021 | 11/15/2021 | ||
|---|---|---|---|---|---|
Exit | IPO | IPO | IPO | ||
Companies | |||||
Valuation | |||||
Acquirer | Public | Public | Public | ||
Sources | 1 | 1 | 2 |
LYFE Capital Fund History
4 Fund Histories
LYFE Capital has 4 funds, including LYFE Capital Fund IV.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
4/22/2022 | LYFE Capital Fund IV | $935M | 1 | ||
10/11/2019 | LYFE Capital Fund III | ||||
5/30/2017 | LYFE Capital II | ||||
LYFE Capital Fund III (Phoenix) |
Closing Date | 4/22/2022 | 10/11/2019 | 5/30/2017 | |
|---|---|---|---|---|
Fund | LYFE Capital Fund IV | LYFE Capital Fund III | LYFE Capital II | LYFE Capital Fund III (Phoenix) |
Fund Type | ||||
Status | ||||
Amount | $935M | |||
Sources | 1 |
LYFE Capital Team
7 Team Members
LYFE Capital has 7 team members, including current Founder, Managing Partner, James Zhao.
Name | Work History | Title | Status |
|---|---|---|---|
James Zhao | Founder, Managing Partner | Current | |
Roy Xu | Chief Financial Officer | Current | |
Jack Chen | Managing Partner | Current | |
William Chen | Managing Director | Current | |
Yanfei Feng | Managing Director | Current |
Name | James Zhao | Roy Xu | Jack Chen | William Chen | Yanfei Feng |
|---|---|---|---|---|---|
Work History | |||||
Title | Founder, Managing Partner | Chief Financial Officer | Managing Partner | Managing Director | Managing Director |
Status | Current | Current | Current | Current | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.